Institut Jules Bordet — Anderlecht

Public research footprint of Institut Jules Bordet, compiled from the ClinicalTrials.gov public registry.

113

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Non-Small Cell Lung Cancer · Breast Cancer · Prostate Cancer · Advanced or Metastatic Colorectal Cancer

Recently updated registry entries

NCT05217446 — A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to… (Active Not Recruiting)
NCT06662786 — A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI… (Recruiting)
NCT06750094 — A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Institut Jules Bordet?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.